Pharmacological profile of 6, 12-dihydro-3-methoxy-1-benzopyrano [3, 4-b][1, 4] benzothiazin-6-one, a novel human estrogen receptor agonist.

…, Y Ma, A Boulahdour, L Bermont, B Refouvelet…

Index: Jacquot, Yves; Cleeren, Anny; Laios, Ioanna; Ma, Yan; Boulahdour, Athem; Bermont, Laurent; Refouvelet, Bernard; Adessi, Gerard; Leclercq, Guy; Xicluna, Alain Biological and Pharmaceutical Bulletin, 2002 , vol. 25, # 3 p. 335 - 341

Full Text: HTML

Citation Number: 12

Abstract

Pharmacological studies were carried out to characterize further the endocrinological profile and the binding mode to the estrogen receptor (ER) of 6, 12-dihydro-3-methoxy-1- benzopyrano [3, 4-b][1, 4] benzothiazin-6-one (1). Binding experiments were conducted with highly purified recombinant human estrogen receptors hERα and β. Potent estrogenic activity of compound 1 was assessed by testing its ability to down-regulate ERs and to ...

Related Articles:

Synthesis and Mesomorphic Investigations of Liquid Crystalline Compounds Having a Benzothiazole Ring

[Thaker; Chothani; Patel; Dhimmar; Solanki; Patel, Neeraj; Makawana Molecular Crystals and Liquid Crystals, 2013 , vol. 575, # 1 p. 64 - 76]

Synthesis of 7-chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1, 4-benzothiazines as antimicrobial agents

[Bioorganic and Medicinal Chemistry, , vol. 14, # 16 p. 5678 - 5682]

[On the rhodanation of halogen substituted anilines. 24. On the organic rhodan compounds]

[Die Pharmazie, , vol. 22, # 6 p. 229 - 233]

More Articles...